Solving the Antidepressant Efficacy Question: Effect Sizes in Major Depressive Disorder

被引:50
|
作者
Voehringer, Paul A. [1 ,2 ]
Ghaemi, S. Nassir [3 ]
机构
[1] Tufts Med Ctr, Dept Psychiat, Mood Disorders Program, Boston, MA 02111 USA
[2] Univ Chile, Fac Med, Hosp Clin, Santiago 7, Chile
[3] Tufts Univ, Sch Med, Boston, MA 02111 USA
关键词
antidepressants; effect size; meta-analysis; randomized clinical trials; STAR-ASTERISK-D; MAINTENANCE TREATMENT; BIPOLAR DISORDER; VENLAFAXINE; OUTCOMES; DISCONTINUATION; SEVERITY; PREVENT;
D O I
10.1016/j.clinthera.2011.11.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Numerous reviews and meta-analyses of the antidepressant literature in major depressive disorders (MDD), both acute and maintenance, have been published, some claiming that antidepressants are mostly ineffective and others that they are mostly effective, in either acute or maintenance treatment. Objective: The aims of this study were to review and critique the latest and most notable antidepressant MDD studies and to conduct our own reanalysis of the US Food and Drug Administration database studies specifically analyzed by Kirsch et al. Methods: We gathered effect estimates of each MDD study. In our reanalysis of the acute depression studies, we corrected analyses for a statistical floor effect so that relative (instead of absolute) effect size differences were calculated. We also critiqued a recent meta-analysis of the maintenance treatment literature. Results: Our reanalysis showed that antidepressant benefit is seen not only in severe depression but also in moderate depression and confirmed a lack of benefit for antidepressants over placebo in mild depression. Relative antidepressant versus placebo benefit increased linearly from 5% in mild depression to 12% in moderate depression to 16% in severe depression. The claim that antidepressants are completely ineffective, or even harmful, in maintenance treatment studies involves unawareness of the enriched design effect, which, in that analysis, was used to analyze placebo efficacy. The same problem exists for the standard interpretation of those studies, although they do not prove antidepressant efficacy either, since they are biased in favor of antidepressants. Conclusions: In sum, we conclude that antidepressants are effective in acute depressive episodes that are moderate to severe but are not effective in mild depression. Except for the mildest depressive episodes, correction for the statistical floor effect proves that antidepressants are effective acutely. These considerations only apply to acute depression, however. For maintenance, the long-term efficacy of antidepressants is unproven, but the data do not support the conclusion that they are harmful. (Clin Ther. 2011;33:B49-B61) (C) 2011 Elsevier HS Journals, Inc. All rights reserved.
引用
收藏
页码:B49 / B61
页数:13
相关论文
共 50 条
  • [21] Effect of ramelteon coadministered with antidepressant in patients with insomnia and major depressive disorder: an exploratory study
    Uchimura, Naohisa
    Nakatome, Keisuke
    Miyata, Kouji
    Uchiyama, Makoto
    SLEEP AND BIOLOGICAL RHYTHMS, 2019, 17 (04) : 397 - 405
  • [22] Effect of ramelteon coadministered with antidepressant in patients with insomnia and major depressive disorder: an exploratory study
    Naohisa Uchimura
    Keisuke Nakatome
    Kouji Miyata
    Makoto Uchiyama
    Sleep and Biological Rhythms, 2019, 17 : 397 - 405
  • [23] Suicidal ideation and other persisting symptoms after CBT or antidepressant medication treatment for major depressive disorder
    Dunlop, Boadie W.
    Polychroniou, Philip E.
    Rakofsky, Jeffrey J.
    Nemeroff, Charles B.
    Craighead, W. Edward
    Mayberg, Helen S.
    PSYCHOLOGICAL MEDICINE, 2019, 49 (11) : 1869 - 1878
  • [24] Impact of antidepressant treatment on complete blood count parameters and inflammatory ratios in adolescents with major depressive disorder
    Puangsri, Pavarud
    Jinanarong, Vinn
    Ninla-aesong, Putrada
    JOURNAL OF PSYCHIATRIC RESEARCH, 2023, 157 : 26 - 35
  • [25] Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
    Myung, Woojae
    Lim, Shinn-Won
    Woo, Hye In
    Park, Jin Hong
    Shim, Sanghong
    Lee, Soo-Youn
    Kim, Doh Kwan
    PSYCHIATRY INVESTIGATION, 2016, 13 (06) : 644 - 651
  • [26] Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study
    Dam, Vibeke Hoyrup
    Stenbaek, Dea Siggaard
    Kohler-Forsberg, Kristin
    Ip, Cheng
    Ozenne, Brice
    Sahakian, Barbara Jacquelyn
    Knudsen, Gitte Moos
    Jorgensen, Martin Balslev
    Frokjaer, Vibe Gedsoe
    TRANSLATIONAL PSYCHIATRY, 2022, 12 (01)
  • [27] Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder
    Dunlop, Boadie W.
    Cole, Steven P.
    Nemeroff, Charles B.
    Mayberg, Helen S.
    Craighead, W. Edward
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 229 : 111 - 119
  • [28] Choosing a second generation antidepressant for treatment of major depressive disorder
    Lester, Helen
    Gilbody, Simon
    BRITISH MEDICAL JOURNAL, 2012, 344
  • [29] ARPNet: Antidepressant Response Prediction Network for Major Depressive Disorder
    Chang, Buru
    Choi, Yonghwa
    Jeon, Minji
    Lee, Junhyun
    Han, Kyu-Man
    Kim, Aram
    Ham, Byung-Joo
    Kang, Jaewoo
    GENES, 2019, 10 (11)
  • [30] Abnormal Dynamic Functional Connectivity of the Left Rostral Hippocampus in Predicting Antidepressant Efficacy in Major Depressive Disorder
    Xue, Shao-Wei
    Kuai, Changxiao
    Xiao, Yang
    Zhao, Lei
    Lan, Zhihui
    PSYCHIATRY INVESTIGATION, 2022, 19 (07) : 562 - 569